| [1] |
Ambrosini G, Adida C, Altieri DC. A novel anti-apoptosis gene, survivin, expressed in cancer and lymphoma[J]. Nat Med, 19 97,3(8):917-21.
|
| [2] |
Kang DW, Choi CH, Park JY, et al. Ciglitazone induces caspase-independent apoptosis through down-regulation of XIAP and survivin in human glioma cells[J].Neurochem Res, 20 08,33(3):551-61.
|
| [3] |
Esh AM, Atfy M, Azizi NA, et al. Prognostic significance of survivin in pediatric acute lymphoblastic leukemia[J]. Indian J Hematol Blood Transfus, 2011,27(1):18-25.
|
| [4] |
Mahotka C, Krieg T, Krieg A, et al. Distinct in vivo expression patterns of survivin splice variants in renal cell carcinomas[J]. Int J Cancer, 2002,100(1):30-6.
|
| [5] |
Caldas H, Honsey LE, Altura RA. Survivin 2alpha: a novel survivin splice variant expressed in human malignancies[J]. Mol Cancer, 2005,4(1):11.
|
| [6] |
Badran A, Yoshida A, Ishikawa K, et al. Identifi cation of a novel splice variant of the human anti-apoptopsis gene survivin [J]. Biochem Biophys Res Commun, 2004,314(3):902-7.
|
| [7] |
Atlasi Y, Mowla SJ, Ziaee SA. Differential expression of survivin and its splice variants, survivin-DeltaEx3 and survivin-2B, in bladder cancer[J].Cancer Detect Prev, 2009,32(4):308-13.
|
| [8] |
Church DN, Talbot DC. Survivin in solid tumors: rationale for development of inhibitors[J]. Curr Oncol Rep, 2012,14(2):120-8.
|
| [9] |
Shankar SL, Mani S, O’Guin KN, et al. Survivin inhibition induces human neural tumor cell death through caspase-independent and dependent pathways[J]. J Neurochem, 2001,79(2):426-36.
|
| [10] |
O’Driscoll L, Linehan R, Clynes M. Survivin: role in normal cells and in pathological conditions[J]. Curr Cancer Drug Targets, 20 03,3(2):131-52.
|
| [11] |
Kapoor S. Beyond pancreatic carcinoma: The close relationship between survivin levels and prognosis in systemic malignancies[J]. World J Clin Oncol, 2012,3(5):80-1.
|
| [12] |
Basta-Jovanovic G, Radojevic-Skodric S, Brasanac D, et al. Prognostic value of survivin expression in Wilms tumor[J]. J BUON, 2012,17(1):168-73.
|
| [13] |
Guo LD, Chen XJ, Hu YH, et al. Curcumin inhibits proliferation and induces apoptosis of human colorectal cancer cells by activating the mitochondria apoptotic pathway[J]. Phytother Res, 20 12,27(3):422-30.
|
| [14] |
Sánchez-Rovira P, Antón A, Barnadas A, et al. Classical markers like ER and ki-67, but also survivin and pERK, could be involved in the pathological response to gemcitabine, adriamycin and paclitaxel (GAT) in locally advanced breast cancer patients: results from the GEICAM/2002-01 phase II study[J]. Clin Transl Oncol, 2012,14(6):430-6.
|
| [15] |
Ryan B, O’Donovan N, Browne B, et al. Expression of survivin and its splice variants survivin-2B and survivin-DeltaEx3 in breast cancer[J]. Br J Cancer, 2005, 92(1):120-4.
|
| [16] |
Xiong H, Yu S, Zhuang L, et al. Changes of survivin mRNA and protein expression during paclitaxel treatment in breast cancer cells[J]. J Huazhong Univ Sci Technolog Med Sci, 2007, 27 (1):65-7.
|
| [17] |
Huang SJ, Tao JS, Cheng ZJ. Expression of survivin and its spliceosome △Ex3 in peripheral blood of patients with gastrointestinal cancer[J]. Guangdong Yi Yao, 2011, 32 (7):859-62.[黄少军, 陶建蜀, 程正江. Survivin及其剪接变体 △Ex3在胃肠道肿瘤患者外周血中的表达[J]. 广东医学, 2011, 32 (7):859-62.]
|
| [18] |
Zuo WG,Li YY,Nie YQ,et al. Expression of survivin gene and main transcript variants mRNA in colorectal[J].Chongqing Yi Ke Da Xue Xue Bao, 2009, 34(7):852-6.[左文革, 李瑜元, 聂玉强,等. Survivin基因及其主要剪接变构体mRNA在大肠癌组织中的表 达[J] 重庆医科大学学报, 2009, 34(7):852-6.]
|
下载:
